SubscribeLogin
Published

Heath Care Stocks Jittery After RFK Jr. Nomination News

Summary by Money
President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. as secretary of the Department of Health and Human Services has the potential to upend investments in pharmaceutical and health care companies, particularly in the short term, according to analysts. Investors are especially worried that Kennedy’s vocal hostility to vaccines could impact the bottom lines of the companies that make them. Immediately after the announcement of his no…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Donald TrumpDonald Trump
Robert F. Kennedy Jr.Robert F. Kennedy Jr.
FinanceFinance
Washington DCWashington DC
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal